Actively Recruiting

Age: 18Years +
All Genders
ID05888974

Diagnostic Performance of Mitral Annulus Velocity Variation by Tissue Doppler to Evaluate Fluid Responsiveness During Initial Shock Management in Emergency Department

Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2025-12-04

187

Participants Needed

1

Research Sites

20 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating the use of mitral annulus velocity variation (E') measured by tissue Doppler ultrasound as a diagnostic tool to evaluate fluid responsiveness in patients admitted to the emergency department with shock. Shock is characterized by low blood pressure requiring vascular filling, and assessing how patients respond to fluid filling is a critical challenge in emergency medicine. This observational study aims to determine if changes in E' before and after fluid filling can accurately identify patients who benefit from such treatment. During the study, patients with shock and mean arterial pressure below 65 mmHg who require vascular filling will undergo three cardiac ultrasounds. The first ultrasound occurs at the start of a 500 mL fluid infusion, the second immediately after the infusion ends, and the third 20 minutes later. These ultrasounds are part of standard care and are used to monitor heart function and fluid response. The study focuses on measuring the change in E' velocity around the time of fluid administration. Participants will be monitored through these ultrasound assessments during their initial management in the emergency department. The main outcomes measured are the variation in E' velocity and fluid filling responsiveness at the time of inclusion. Additional monitoring includes a later E' measurement. The study seeks to improve diagnostic methods for fluid responsiveness in emergency care, with participation lasting during the initial emergency treatment period.

CONDITIONS

Brief Title

Diagnostic Performance of the Mitral Annulus Velocity Variation Measured by Tissue Doppler to Evaluate the Fluid Responsiveness During the Initial Management of Shock in Patients Admitted to the Emergency Department

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient has been informed of the study and does not refuse to participate.
  • Patient is at least 18 years old.
  • Patient has health insurance coverage.
  • Patient has shock with mean blood pressure less than 65 mmHg.
  • Referring physician has decided on vascular filling with 500 mL of crystalloids (NaCl 0.9% or Ringer lactate).
  • Patient does not have acute intracranial pathology.
Not Eligible

You will not qualify if you...

  • Patient has already received two vascular fillings since treatment began.
  • Patient is in shock with contraindication to vascular filling (cardiogenic or obstructive shock).
  • Patient has intracranial pathology requiring mean arterial pressure of at least 80 mmHg.
  • Patient is intubated or on Non-Invasive Ventilation before vascular filling.
  • Patient is under court protection.
  • Patient is pregnant, parturient, or nursing.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Within a few hours on the day of inclusion

Participants undergo cardiac ultrasonography to evaluate fluid responsiveness during initial shock management in the emergency department.

1 inclusion visit with 3 ultrasound assessments (at initiation of vascular filling, at end of filling, and 20 minutes after filling)

Long-term Monitoring

Duration - Up to study completion

Participants are observed for outcomes related to fluid responsiveness and cardiac function after initial diagnostic evaluation.

No additional specific visits; observations are based on clinical follow-up

Trial Site Locations

Total: 1 location

1

CHU de Nîmes

Nîmes, France, 34000

Actively Recruiting

Loading map...

Research Team

L

Laura GRAU MERCIER, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Acutelines: a Large Biobank Aiming to Improve Early Recognit...

Acute Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here